Russia’s EpiVacCorona Vaccine Develops Antibodies in 94% of Senior Citizens, Developer Says

Apr 7, 2021 | EARNINGS

MOSCOW (Sputnik) – As many as 94 percent of senior citizens develop antibodies against the coronavirus after being inoculated with Russia’s EpiVacCorona vaccine, the head of the Yekaterinburg department of Russia’s Vector research institute that developed the vaccine said on Wednesday.

Read More

Pin It on Pinterest